As MGIC Investment Corp prepares to unveil its quarterly financial results, a notable transaction by its chief executive has captured investor attention. Timothy J. Mattke, the company’s CEO, recently disposed of a substantial block of shares, raising questions as the market anticipates Monday’s earnings report and whether it can reverse the stock’s recent lagging performance.
Quarterly Expectations and Market Forecasts
The provider of private mortgage insurance is scheduled to report its fourth-quarter earnings after U.S. markets close on Monday. Market consensus points to a period of steady, if slower, growth. Revenue projections from analysts cluster between $307.1 million and $308.2 million, which would represent a year-over-year increase of approximately 1.9%. This projected growth rate marks a significant deceleration from the 6.2% rise recorded in the same quarter of the previous year.
Regarding profitability, the average estimate for adjusted earnings per share (EPS) stands at $0.75. The company has recently demonstrated operational efficiency; in Q3 2025, MGIC Investment managed to exceed analyst EPS expectations by $0.11 despite flat revenue figures.
Understanding the Insider Transaction
In mid-January, CEO Timothy J. Mattke sold 139,203 shares of the company, generating proceeds of roughly $3.69 million. For shareholders evaluating this move, the execution mechanism is a critical detail. The sale was conducted pursuant to a Rule 10b5-1 trading plan established in May 2025.
Should investors sell immediately? Or is it worth buying Mgic Investment?
These pre-arranged plans allow corporate executives to schedule transactions months in advance, thereby avoiding potential conflicts with non-public information. Consequently, this divestment is more indicative of long-term personal financial planning by the CEO rather than an immediate reaction to the company’s current business outlook or the impending earnings announcement.
Institutional Sentiment and Valuation Gap
Despite the stock underperforming its property and casualty insurance sector peers in January, certain institutional investors have shown conviction. Notably, Lingohr Asset Management significantly increased its stake during the third quarter, accumulating over 233,500 shares.
The equity currently trades below the average price target set by analysts. These targets generally range from $28.00 to $29.00, with a consensus near $28.75. The immediate market reaction following Monday’s earnings release will indicate whether the stock can begin to close this valuation gap. Furthermore, the analyst conference call scheduled for Tuesday morning is expected to provide crucial insights into management’s strategy for potentially reaccelerating growth momentum for the 2026 fiscal year.
Key Data Points:
* Earnings Release: Monday after the U.S. market close.
* Revenue Forecast: $307.1 million to $308.2 million (up 1.9% year-over-year).
* EPS Forecast: Consensus estimate of $0.75 per share.
* Insider Activity: CEO sold shares worth $3.69 million via a pre-arranged trading plan.
* Price Target: Average analyst target is approximately $28.75.
Ad
Mgic Investment Stock: Buy or Sell?! New Mgic Investment Analysis from February 1 delivers the answer:
The latest Mgic Investment figures speak for themselves: Urgent action needed for Mgic Investment investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 1.
Mgic Investment: Buy or sell? Read more here...
